Concepedia

Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma

Tessa Gargett, M. Nazim Abbas, Paul Rolan, Jason D. Price, Katharine M. Gosling, Antonio Ferrante, Andrew Ruszkiewicz, Ines I. Atmosukarto, Joseph G. Altin, Christopher R. Parish,

Cancer Immunology Immunotherapy · 2018 · 109 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

, , +16

Final Version of 2009 AJCC Melanoma Staging and Classification

Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text

, , +17

Cancer immunotherapy: moving beyond current vaccines

Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text

, , +14

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Stefani Spranger, Riyue Bao, Thomas F. Gajewski · Nature · 2015 · 2.8K citations

, , +10

Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

Teunis B. H. Geijtenbeek, Ruurd Torensma, Sandra J. van Vliet et al. · Cell · 2000 · 1.7K citations · Full text

, , +12